Full Text View
Tabular View
No Study Results Posted
Related Studies
Methamphetamine Abuse Treatment in Patients With AIDS - 1
This study has been completed.
Study NCT00000321   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes

September 20, 1999
August 16, 2005
October 1996
 
  • Craving
  • Retention
  • Depression
  • Methamphetamine use
  • Anxiety and Depression
  • ASI Scales (7)
  • AIDS medical care engagement
  • High risk sexual behaviors
  • Mood indicators
Same as current
Complete list of historical versions of study NCT00000321 on ClinicalTrials.gov Archive Site
 
 
 
Methamphetamine Abuse Treatment in Patients With AIDS - 1
Methamphetamine Abuse Pharmacology in Patients With AIDS

The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.

 
Phase IV
Interventional
Treatment
Substance-Related Disorders
Drug: Desipramine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
December 2001
 

Please contact site for information.

Male
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000321
 
NIDA-10643-1, R01-10643-1
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.
Principal Investigator: Frank Gawin, M.D. Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
October 1996

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP